top of page
Search

Vulvovaginal Candidiasis Market Projected to Witness Vigorous Expansion by 2030

  • Writer: chhaya chavan
    chhaya chavan
  • May 17, 2023
  • 3 min read

The market for Vulvovaginal Candidiasis (VVC) was valued at USD 971.51 million in 2021 and is anticipated to grow at a 4.2% CAGR in terms of revenue during the projected period. The rise in vulvovaginal candidiasis infections in women around the world, rising regulatory approvals for vulvovaginal candidiasis treatments, and an increase in clinical research studies into vulvovaginal candidiasis treatments are key factors propelling this market's revenue growth.

The report is a comprehensive research study of the global Vulvovaginal Candidiasis market inclusive of the latest trends, growth factors, developments, opportunities, and competitive landscape. The research study includes an in-depth analysis of the market using advanced research methodologies such as SWOT analysis and Porter’s Five Forces analysis. The report is formulated with data gathered from primary and secondary research examined and validated by industry experts. The report provides an overview of the market leaders, segmentation by type, application, and region, and technological advancements.

Key companies operating in the Vulvovaginal Candidiasis market include:

Mycovia Pharmaceuticals, Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc, Cadila Pharmaceuticals., SCYNEXIS, Inc., Grupo Ferrer International S.A., Phathom Pharmaceuticals, Inc., and Lupin

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Vulvovaginal Candidiasis market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Key Benefits of the Report:

  • Critical understanding of the key market segments

  • Comprehensive analysis of the drivers, restraints, trends, and opportunities

  • Comprehensive analysis of the competitive scenario and its changing dynamics

  • Analytical data with detailed SWOT analysis and Porter’s Five Forces analysis

  • In-depth 8-year analysis of the Global Vulvovaginal Candidiasis Market

  • Detailed regional analysis and extensive company profiling

  • Extensive assessment of current and emerging trends of the market

Vulvovaginal Candidiasis Market Segmentation:

  • Drug Type Outlook (Revenue, USD Million; 2019-2030)

    • Clotrimazole

    • Fluconazole

    • Ketoconazole

    • Terbinafine

    • Terconazole

    • Others


  • Route of Administration Outlook (Revenue, USD Million; 2019-2030)

    • Oral

    • Topical

    • Intravenous


  • Distribution Channel Outlook (Revenue, USD Million; 2019-2030)

    • Hospitals Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

Vulvovaginal Candidiasis Market Segmentation by Regions:

  • North America (U.S., Canada)

  • Europe (U.K., Italy, Germany, France, Rest of EU)

  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)

  • Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.

More Related Reports By Emergen ResearchWorkforce Management Market



Product Lifecycle Management Market



Micro Irrigation Systems Market



Malware Analysis Market



Pet Clothing Market



Acne Treatment Market



Hardware Security Modules Market



Game Based Learning Market



Cannabis Cultivation Market



Silica Gel Market



Electric Vehicle Car Polymers Market



Sun Protection Market



Matcha Market


About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

 
 
 

Recent Posts

See All

Comments

bottom of page